# IGC Pharma, Inc.: Form 8-K, filed Apr 12, 2018

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2018-04-12
- Accepted by EDGAR: Apr 11, 2018, 18:18 ET
- Period: 2018-04-11
- Accession: 0001185185-18-000677
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518518000677/indiaglobalization8k041118.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518518000677/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518518000677/indiaglobalization8k041118.htm

Filed Apr 12, 2018.
Source: SEC EDGAR, the filing index for accession 0001185185-18-000677. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
